ETX.L Share News (ETX)

ETX.L Information

There is currently no data for ETX

E-Therapeutics Appoints Sean Nicholson As Executive Director

Thu, 16th Oct 2014 07:40

LONDON (Alliance News) - E-Therapeutics PLC on Thursday said Sean Nicholson has been appointed as an executive director on its board.

Nicholson will join the board of the drug company in 2015 following his resignation as an equity partner in the corporate team at law firm Bond Dickinson LLP, the company said.

"Sean brings a wealth of knowledge and strong commercial skills. We intend to put his experience to good use as we continue to advance our drug development portfolio and apply our network pharmacology approach in drug discovery," said e-Therapeutics Chief Executive Officer Malcolm Young.

E-Therapeutics shares were untraded early Thursday, quoted at 28.25 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

More News

29 Jun 2010 16:00

UK SMALLCAP ROUNDUP: E-Therapeutics Seeks Pharma Alliances

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps E-THERAPEUTICS PLC (ETX.LN), a U.K. drug developer, said Tuesday its focus this year and next will be on clinical trials of its experimental medicines an

29 Jun 2010 12:06

INTERVIEW: E-Therapeutics Readies Trials, Seeks Alliances

By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--U.K. drug developer e-Therapeutics PLC (ETX.LN) Tuesday said its focus this year and next will be on clinical trials of its experimental medicines and securing alliances with pharmaceutical companies. E-Therapeutics, which uses

29 Jun 2010 11:03

Small caps round-up: Northern Bear, Airsprung, Pursuit Dynamics...

Support services group Northern Bear stretched its strong run Tuesday after claiming a good start to the new financial year, with its order book and pipeline well up on a year ago. "The board is pleased to announce that the new financial year has started well, with strong order books and a healthy

29 Jun 2010 08:01

E-Therapeutics Loss Widens; In Talks With Drug Makers

LONDON (Dow Jones)--Drug discovery company e-Therapeutics PLC (ETX.LN) Tuesday reported a wider fiscal-year loss and said it remains in talks with drug makers about commercial collaborations. E-Therapeutics, which uses computer software to develop new drugs, added the first of several planned Ph

2 Mar 2010 16:33

Chairman's wife buys Redrow shares

Redrow chairman Steve Morgan's wife has bought 100,000 shares in the housebuilder taking their combined stake to 29.95%. Fiona Morgan paid 131.5p a share for the 100,000 shares. The total cost was £131,500. Morgan founded Redrow in 1974 and floated the company 20 years later. He also owns Wolver

27 Jul 2009 08:38

e-Therapeutics narrows losses

Drug discovery and development company e-Therapeutics said annual losses narrowed and it remains confident of becoming cash generative. For the year ended 31 January loss before tax narrowed to £1.96m from a loss of £2.2m the year before. Revenue increased to £67,000 from £64,000 the previous year.

Latest Share Chat

ETX.L Share News (ETX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

E-Therapeutics Appoints Sean Nicholson As Executive Director

UK SMALLCAP ROUNDUP: E-Therapeutics Seeks Pharma Alliances

INTERVIEW: E-Therapeutics Readies Trials, Seeks Alliances

Small caps round-up: Northern Bear, Airsprung, Pursuit Dynamics...

E-Therapeutics Loss Widens; In Talks With Drug Makers

Chairman's wife buys Redrow shares

e-Therapeutics narrows losses

Login to your account

Quickpicks are a member only feature

Login to your account